ORASURE TECHNOLOGIES, INC APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition
ORASURE TECHNOLOGIES, INC (OSUR) reported APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition of $2.98 million for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-02.
Discontinued › Shareholders' Equity › APIC, Share-Based Payment Arrangement, Increase for Cost Recognition
us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition · last filed 2020-03-02
- ORASURE TECHNOLOGIES, INC apic, share-based payment arrangement, restricted stock unit, increase for cost recognition for the quarter ending 2019-12-31 was $594.00K.
- ORASURE TECHNOLOGIES, INC apic, share-based payment arrangement, restricted stock unit, increase for cost recognition for the quarter ending 2019-09-30 was $858.00K, a 45.67% increase year-over-year.
- ORASURE TECHNOLOGIES, INC apic, share-based payment arrangement, restricted stock unit, increase for cost recognition for the quarter ending 2019-06-30 was $874.00K, a 38.41% decline year-over-year.
- ORASURE TECHNOLOGIES, INC apic, share-based payment arrangement, restricted stock unit, increase for cost recognition for the quarter ending 2019-03-31 was $653.00K, a 81.99% decline year-over-year.
- ORASURE TECHNOLOGIES, INC apic, share-based payment arrangement, restricted stock unit, increase for cost recognition for fiscal 2019 was $2.98M, a 53.14% decline from fiscal 2018.
- ORASURE TECHNOLOGIES, INC apic, share-based payment arrangement, restricted stock unit, increase for cost recognition for fiscal 2018 was $6.36M, a 135.01% increase from fiscal 2017.
- ORASURE TECHNOLOGIES, INC apic, share-based payment arrangement, restricted stock unit, increase for cost recognition for fiscal 2017 was $2.71M, a 5.45% decline from fiscal 2016.
- ORASURE TECHNOLOGIES, INC apic, share-based payment arrangement, restricted stock unit, increase for cost recognition for fiscal 2016 was $2.86M, a 8.29% increase from fiscal 2015.
| Period end | APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition 12 month | APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition 12 month as first filed |
|---|---|---|---|---|---|
| 2019-12-31 | $594.00K derived: 10-K 12 month − 3 quarters · filed 2020-03-02 | $1.45M derived: sum of 2 quarters · filed 2020-03-02 | $2.33M derived: sum of 3 quarters · filed 2020-03-02 | $2.98M 10-K · filed 2020-03-02 | |
| 2019-09-30 | $858.00K 10-Q · filed 2019-11-08 | $1.73M derived: sum of 2 quarters · filed 2019-11-08 | $2.38M derived: sum of 3 quarters · filed 2019-11-08 | ||
| 2019-06-30 | $874.00K 10-Q · filed 2019-11-08 | $1.53M derived: sum of 2 quarters · filed 2019-11-08 | |||
| 2019-03-31 | $653.00K 10-Q · filed 2019-11-08 | ||||
| 2018-12-31 | $6.36M 10-K · filed 2020-03-02 | ||||
| 2018-09-30 | $589.00K 10-Q · filed 2019-11-08 | $2.01M derived: sum of 2 quarters · filed 2019-11-08 | $5.63M derived: sum of 3 quarters · filed 2019-11-08 | ||
| 2018-06-30 | $1.42M 10-Q · filed 2019-11-08 | $5.04M derived: sum of 2 quarters · filed 2019-11-08 | |||
| 2018-03-31 | $3.63M 10-Q · filed 2019-11-08 | ||||
| 2017-12-31 | $2.71M 10-K · filed 2020-03-02 | ||||
| 2016-12-31 | $2.86M 10-K · filed 2019-02-28 | ||||
| 2015-12-31 | $2.64M 10-K · filed 2018-02-28 | ||||
| 2014-12-31 | $2.66M 10-K · filed 2017-03-14 | ||||
| 2013-12-31 | $2.88M 10-K · filed 2016-03-14 | ||||
| 2012-12-31 | $2.89M 10-K · filed 2015-03-12 | ||||
| 2011-12-31 | $2.52M 10-K · filed 2014-03-14 | $2.52M 10-K · filed 2012-03-14 | |||
| 2010-12-31 | $2.35M 10-K · filed 2013-03-13 | $2.35M 10-K · filed 2012-03-14 | |||
| 2009-12-31 | $2.62M 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |